Prevalência e perfil de susceptibilidade de Escherichia coli isolada de uroculturas na emergência adulta de um hospital privado

Maria Goreth Matos de Andrade Barberino, Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Gabriela Noronha Marques(Hospital São Rafael), Camila Araujo de Lourenzo Barcia, Thamires Gomes Lopes Weber(Hospital São Rafael), Lara Sbarro

Unknown

January 1, 2025

10.5327/1516-3180.cbpc/ml.15436

Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

|The Lancet|2020|5k

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

|The Lancet|2021|1.2k

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

|The Lancet|2022|467

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil

|Emerging infectious diseases|2021|215

Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

|Biomedicine & Pharmacotherapy|2021|121